Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Medecine Sciences : M/S
|
March 23, 2024
[Therapeutics in cystic fibrosis: Clinical revolution and new challenges]
Emmanuelle Bardin, Iwona Pranke, Alexandre Hinzpeter, et al.
Frontiers in Pharmacology
|
March 16, 2019
Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
Iwona Pranke, Anita Golec, Alexandre Hinzpeter, et al.
Journal of Personalized Medicine
|
August 27, 2021
Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
Isabelle Sermet-Gaudelus, Thao Nguyen-Khoa, Aurélie Hatton, et al.
La Revue Du Praticien
|
January 23, 2026
[Treatment perspectives for patients not eligible for therapies for cystic fibrosis]
Emmanuelle Bardin, Iwona Pranke, Marie Giorgi, et al.
Seminars in Respiratory and Critical Care Medicine
|
November 4, 2019
Cystic Fibrosis Diagnosis in Newborns, Children, and Adults
Carlo Castellani, Barry Linnane, Iwona Pranke, et al.
Journal of Visualized Experiments : Jove
|
May 9, 2022
Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine
Mairead Kelly, Elise Dreano, Aurelie Hatton, et al.
STAR Protocols
|
June 6, 2022
Isolation, cultivation, and application of primary respiratory epithelial cells obtained by nasal brushing, polyp samples, or lung explants
Anita Golec, Iwona Pranke, Paolo Scudieri, et al.
International Journal of Molecular Sciences
|
December 23, 2022
Acting on the CFTR Membrane-Spanning Domains Interface Rescues Some Misfolded Mutants
Nesrine Baatallah, Ahmad Elbahnsi, Benoit Chevalier, et al.
F1000Research
|
November 27, 2015
An unexpected effect of TNF-α on F508del-CFTR maturation and function
Sara Bitam, Iwona Pranke, Monika Hollenhorst, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 18, 2018
Might Brushed Nasal Cells Be a Surrogate for CFTR Modulator Clinical Response?
Iwona Pranke, Aurelie Hatton, Alexandra Masson, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Medecine Sciences : M/S
|
March 23, 2024
[Therapeutics in cystic fibrosis: Clinical revolution and new challenges]
Emmanuelle Bardin, Iwona Pranke, Alexandre Hinzpeter, et al.
Frontiers in Pharmacology
|
March 16, 2019
Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
Iwona Pranke, Anita Golec, Alexandre Hinzpeter, et al.
Journal of Personalized Medicine
|
August 27, 2021
Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
Isabelle Sermet-Gaudelus, Thao Nguyen-Khoa, Aurélie Hatton, et al.
La Revue Du Praticien
|
January 23, 2026
[Treatment perspectives for patients not eligible for therapies for cystic fibrosis]
Emmanuelle Bardin, Iwona Pranke, Marie Giorgi, et al.
Seminars in Respiratory and Critical Care Medicine
|
November 4, 2019
Cystic Fibrosis Diagnosis in Newborns, Children, and Adults
Carlo Castellani, Barry Linnane, Iwona Pranke, et al.
Journal of Visualized Experiments : Jove
|
May 9, 2022
Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine
Mairead Kelly, Elise Dreano, Aurelie Hatton, et al.
STAR Protocols
|
June 6, 2022
Isolation, cultivation, and application of primary respiratory epithelial cells obtained by nasal brushing, polyp samples, or lung explants
Anita Golec, Iwona Pranke, Paolo Scudieri, et al.
International Journal of Molecular Sciences
|
December 23, 2022
Acting on the CFTR Membrane-Spanning Domains Interface Rescues Some Misfolded Mutants
Nesrine Baatallah, Ahmad Elbahnsi, Benoit Chevalier, et al.
F1000Research
|
November 27, 2015
An unexpected effect of TNF-α on F508del-CFTR maturation and function
Sara Bitam, Iwona Pranke, Monika Hollenhorst, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 18, 2018
Might Brushed Nasal Cells Be a Surrogate for CFTR Modulator Clinical Response?
Iwona Pranke, Aurelie Hatton, Alexandra Masson, et al.
Page
of 4